Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Caro

Showing results (101-110 of 257) with videos related to

Pageof 26
Sort By:
Stroke|March 4, 2000
Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis GroupJ J Caro, K F Huybrechts, I Duchesne
Scandinavian Journal of Haematology|August 1, 1982
Serum erythropoietin levels by radioimmunoassay in polycythaemiaG Birgegård, O Miller, J Caro, et al.
American Journal of Hematology|April 3, 2001
Refractory autoimmune thrombocytopenic purpura treatment with RituximabK Patel, J Berman, A Ferber, et al.
Cancer|January 9, 2001
Could chest X-ray screening for lung cancer be cost-effective?J J Caro, W S Klittich, G Strauss
Kidney International|February 1, 1997
Complex role of protein phosphorylation in gene activation by hypoxiaS Salceda, I Beck, V Srinivas, et al.
Transfusion Medicine Reviews|October 1, 1989
Is there an optimal hemoglobin level?A J Erslev, J Caro, S J Schuster
The Journal of Laboratory and Clinical Medicine|June 1, 1987
Long-term marrow cultures from mice with busulfan-induced chronic latent aplasiaK G Halka, J Caro, A J Erslev
European Journal of Haematology|November 1, 1989
Erythropoietin and its clinical promiseA J Erslev, S J Schuster, J Caro
Pharmacoeconomics|December 1, 2007
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?Denis Getsios, Kristen Migliaccio-Walle, Jaime J Caro
The Journal of Laboratory and Clinical Medicine|July 1, 1984
In vitro effect of captopril and three captopril metabolites on neutrophilic progenitor cells from normal mice and mice given busulfanR L Boyd, A J Erslev, J Caro
Pageof 26

Showing results (101-110 of 257) with videos related to

Sort By:
Pageof 26
Stroke|March 4, 2000
Management patterns and costs of acute ischemic stroke : an international study. For the Stroke Economic Analysis GroupJ J Caro, K F Huybrechts, I Duchesne
Scandinavian Journal of Haematology|August 1, 1982
Serum erythropoietin levels by radioimmunoassay in polycythaemiaG Birgegård, O Miller, J Caro, et al.
American Journal of Hematology|April 3, 2001
Refractory autoimmune thrombocytopenic purpura treatment with RituximabK Patel, J Berman, A Ferber, et al.
Cancer|January 9, 2001
Could chest X-ray screening for lung cancer be cost-effective?J J Caro, W S Klittich, G Strauss
Kidney International|February 1, 1997
Complex role of protein phosphorylation in gene activation by hypoxiaS Salceda, I Beck, V Srinivas, et al.
Transfusion Medicine Reviews|October 1, 1989
Is there an optimal hemoglobin level?A J Erslev, J Caro, S J Schuster
The Journal of Laboratory and Clinical Medicine|June 1, 1987
Long-term marrow cultures from mice with busulfan-induced chronic latent aplasiaK G Halka, J Caro, A J Erslev
European Journal of Haematology|November 1, 1989
Erythropoietin and its clinical promiseA J Erslev, S J Schuster, J Caro
Pharmacoeconomics|December 1, 2007
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?Denis Getsios, Kristen Migliaccio-Walle, Jaime J Caro
The Journal of Laboratory and Clinical Medicine|July 1, 1984
In vitro effect of captopril and three captopril metabolites on neutrophilic progenitor cells from normal mice and mice given busulfanR L Boyd, A J Erslev, J Caro
Pageof 26